Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0125
0.00 (0.00%)
Last updated: May 21, 2026, 8:08 AM CEST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €6.82 million as of October 28, 2026. Its market cap has decreased by 45.42% in one year.
Market Cap
6.82M
Enterprise Value
-3.82M
Revenue
5.05M
Global Rank
n/a
Country Rank
n/a
PE Ratio
0.36
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 6.82M, a decrease of -99.37%. That is a compound annual growth rate of -35.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 6.82M | 16.28% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 63.50B |
| Siemens Healthineers AG | 47.41B |
| Bayer Aktiengesellschaft | 45.22B |
| Fresenius SE & Co. KGaA | 26.10B |
| MeVis Medical Solutions AG | 36.76M |
| aap Implantate AG | 20.59M |
| NanoRepro AG | 19.87M |
| Biofrontera AG | 18.47M |